AstraZeneca CEO calls for increased European investment in pharma
CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.
Biopharmaceutical Industry
Small biotechs shoulder the burdens of an uncertain biopharma sector
MSD’s Gardasil sales slide further due to China constraints
FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline
J&J projects $400m tariff hit but raises sales outlook
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit
Keros Therapeutics considers sale amid investor pressure
MHRA reconfirmed as WHO biologics partner amid US withdrawal
